Adults in Puerto Rico aware of genetic testing, but use remains low

Oct 02, 2010

Awareness of genetic testing was higher among adults in Puerto Rico compared to previous U.S. population-based studies, while use of genetic testing was lower, according to data presented at the Third AACR Conference on the Science of Cancer Health Disparities, held Sept. 30 to Oct 3, 2010.

Genetic tests are increasingly being offered direct-to-consumers through the Internet and other venues, providing individual access to genetic tests without the involvement or consultation of a health care provider. Researchers analyzed data from the National Trends Survey (HINTS) conducted in Puerto Rico in 2009. Adults were asked whether they had heard or read about genetic tests offered by companies that analyze DNA, diet and lifestyles for potential health risks.

"This study is the first to measure awareness and use of direct-to-consumer genetic tests among adults in Puerto Rico, and to identify factors associated with awareness in this population," said Ana P. Ortiz Martinez, M.P.H., Ph.D., associate professor and researcher in the department of biostatistics and epidemiology at the University of Puerto Rico Cancer Center and Graduate School of Public Health, University of Puerto Rico.

"While 56 percent of those surveyed were aware of these tests, only 4.3 percent had ever used one," said Ortiz, who led the study. "No differences were seen by age or sex, nor was a personal or family history of cancer associated with greater awareness."

By comparison, two previous studies showed lower awareness in the United States. In 2006, only 14 percent of adults said they were aware of genetic testing, according to data from a U.S. HealthStyles national survey. Awareness increased to 29 percent in the 2007 U.S. HINTS survey.

Although causal attributions cannot be determined from these data, the greater awareness and use of genetic testing observed in Puerto Rico relative to mainland estimates coincides with greater push and availability of such tests over time. These data underscore and inform the imperative for population-based outreach and education efforts to provide accurate and balanced information about the risks and benefits of testing.

Use of genetic testing in the 2009 Puerto Rico HINTS survey was lower (4.3 percent) compared with the 2007 U.S. survey (8.1 percent), but higher compared with the 2006 U.S. survey (0.6 percent).

Married people — and those who had ever been married or were living together — were more likely to be aware of direct-to-consumer genetic tests compared with those who never married. Individuals who had sought cancer information were twice as likely to be aware. Smokers were among the least likely to know about genetic testing.

"Further studies will elucidate the use of genetic tests in clinical settings, and evaluate attitudes and beliefs about them," Ortiz said. "As our understanding of their usefulness increases, we must assure access for everyone who may benefit, so that will not become a source of health disparity in the population."

Explore further: No danger of cancer through gene therapy virus

add to favorites email to friend print save as pdf

Related Stories

Genetic tests advertised directly to the consumer

Jul 21, 2009

Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers' response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, ...

At Home Genomic Tests for Disease Risk Premature

Mar 18, 2008

The recent marketing of "at home" genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center (MSKCC).

Recommended for you

No danger of cancer through gene therapy virus

48 minutes ago

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

The secret of DNA methylation

Jun 18, 2013

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression ...

Aspirin may fight cancer by slowing DNA damage

Jun 18, 2013

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

Study identifies protein essential for normal heart function

Jun 17, 2013

A study by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology at the University of California, San Diego, shows that a protein called MCL-1, which promotes cell survival, ...

Scouring the genome of adenoid cystic carcinoma

Jun 17, 2013

Adenoid cystic carcinoma (ACC) is a slow-growing and often fatal malignancy that can occur at multiple organ site, but is most frequently found in the salivary glands. The primary treatment is surgical removal; however, the ...

User comments : 0

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Tech companies eye security that goes beyond passwords

In late February, a thief or thieves cracked into Evernote's digital vault filled with log-ins, passwords and email addresses belonging to 50 million users. It was a shocking cyberattack considering the Redwood City, Calif., ...